HWM
CRL icon

Hemington Wealth Management’s Charles River Laboratories CRL Stock Holding History

Hemington Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17K Buy
111
+30
+37% +$4.76K ﹤0.01% 690
2025
Q2 		$12K Sell
81
-18
-18% -$2.4K ﹤0.01% 781
2025
Q1 		$14K Buy
99
+8
+9% +$1.34K ﹤0.01% 685
2024
Q4 		$16K Sell
91
-8
-8% -$1.54K ﹤0.01% 612
2024
Q3 		$17K Buy
+99
New +$20.6K ﹤0.01% 551

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hemington Wealth Management's CRL Position: Q3 2025 in Review

Hemington Wealth Management increased its Charles River Laboratories (CRL) stake by 37% in Q3 2025, buying an estimated $4.76K and bringing the position to 111 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Hemington Wealth Management first reported a position in CRL in Q3 2024 and has held it in 5 quarters since. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Hemington Wealth Management held 111 shares of Charles River Laboratories worth $17K as of Q3 2025.
  • Hemington Wealth Management bought 30 Charles River Laboratories shares in Q3 2025, an estimated $4.76K.
  • Charles River Laboratories made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #690 holding.
  • Hemington Wealth Management first reported a position in Charles River Laboratories in Q3 2024 and has held it in 5 quarters since.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.